Congratulations to Linnaeus for receiving clearance from the FDA for the company's investigational new drug application (IND) for LNS8801...
Read more
We are delighted to announce that Linnaeus Therapeutics, Inc. has closed a $12 million series B financing led by...
Read more
Foldax, Inc. announced its first-in-human use of the Tria heart valve under its FDA Early Feasibility Study (EFS) for...
Read more
Kairos Ventures portfolio company, Tanvas, proudly welcomes Phillip LoPresti as Chief Executive Officer. Tanvas, the surface haptic pioneer positions...
Read more
Kairos Ventures portfolio company Tanvas joined forces with Mimo Monitors to launch the Mimo Vue with TanvasTouch at InfoComm...
Read more
Kairos Ventures portfolio company MixComm has appointed Mike Noonen as CEO. The semiconductor veteran joins the leadership team that...
Read more
We are delighted to announce that Actuate Therapeutics is the latest company to join the Kairos portfolio. Founded in...
Read more
We are happy to announce that Xidas is the latest company to join the Kairos portfolio. Xidas is a...
Read more
Rana Gujral has been selected as one of Inc.’s top A.I. entrepreneurs to watch. Rana is CEO of Behavioral...
Read more
3D Bio announced the appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to its Board of Directors. Dr....
Read more